The Quiet Before the Storm

You’re going to be castrated before this is all said and done. Markets are flat for the year. German co-pilots have become terrorists, crashing into mountains. Saudi Arabia is now a military force to be reckoned with. Janet Yellen is a super-grandmother. GDP is weak; but who gives a shit?

Early this morning, ICPT caught an upgrade, accompanied with a price target increase from $300 to $400. I don’t think you people understand how big their prospective NASH drug is. If approved, we are talking about the biggest liver treatment drug ever. The stock goes to $700 or $40, nothing in between.

The friendly folks over at iBC are putting the finishing touches on The PPT 2.0, aka Exodus. Next week I am going to expand the beta trials to a select group of people. If you want to be part of the trials, email me: [email protected]. In your email, please let me know if you’re a current member, former member, or thinking about becoming a member of our service. As you know, this has been a very long road for me, a project that has taken nearly a 6 years to complete. Now that I am here, ready to launch this thing, I almost feel like tossing myself into a fireplace lit with fire logs.

Without question, this is one of the great accomplishments of my young life, something that I am immensely proud of and feel offers a tangible value proposition to anyone who plays the market. Naturally, since it was made with space-aged thinking, courtesy of my space alien magician brain, it is decades ahead of the competition, if not centuries.

Having said that, biotech stocks look strong as balls early going. The bears are simply walking into an oddball trap, one that comically severs their heads and catapults their headless bodies into make-shift bonfires.